💊 Samtica 250 mg Tablet | Abiraterone Acetate | Prostate Cancer Treatment | Export Supplier
Samtica 250 mg Tablet contains Abiraterone Acetate, an advanced hormonal therapy used in the treatment of metastatic prostate cancer. It works by reducing androgen (testosterone) production, helping to slow down cancer growth and progression.
🔹 Composition
Abiraterone Acetate 250 mg
🔹 Indications
✔ Metastatic Castration-Resistant Prostate Cancer (mCRPC)
✔ Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
🔹 Key Benefits
✔ Targeted hormonal therapy
✔ Reduces androgen production
✔ Improves disease control in advanced cancer
✔ Widely used in oncology treatment protocols
🔹 Dosage & Administration
✔ Oral tablet as prescribed
✔ Taken on an empty stomach
✔ Used with prednisone or corticosteroid
✔ Under strict medical supervision
🔹 Packaging
✔ Blister / Bottle Packaging
✔ Bulk Export Available
✔ Private Labeling Supported
🔹 Certifications
✔ WHO-GMP Certified
✔ COA & COPP Available
🌍 Target Export Markets
USA, UK, UAE, Singapore
India, Philippines, Vietnam
South Africa, Nigeria, Kenya
Brazil, Mexico, Peru
📍 Location: Nagpur, Maharashtra, India
📦 Product Catalogue Available
✔ Oncology Medicines
✔ HIV & Antiviral Medicines
✔ Specialty Pharmaceutical Products
📞 Instant Support – Call / WhatsApp Now
💬 Quick replies for urgent orders & inquiries!
🌐 Visit Our Official Websites
📧 Business Enquiries & Bulk Orders
🔖 Trending Hashtags
#Oncology #CancerTreatment #ProstateCancer #Abiraterone #PharmaExport #GlobalPharma #Pharmaceuticals #HealthcareIndustry #MedicineSupplier #B2BPharma #GenericMedicines #InternationalTrade #IndiaPharma #NagpurBusiness #OncologyMedicines #CancerCare #ExportBusiness
